Cover Image
市場調查報告書

正黏液病毒感染疾病:全球臨床實驗檢討

Orthomyxoviridae Infections Global Clinical Trials Review, H2, 2014

出版商 GlobalData 商品編碼 322178
出版日期 內容資訊 英文 141 Pages
訂單完成後即時交付
價格
Back to Top
正黏液病毒感染疾病:全球臨床實驗檢討 Orthomyxoviridae Infections Global Clinical Trials Review, H2, 2014
出版日期: 2014年12月31日 內容資訊: 英文 141 Pages
簡介

本報告提供正黏液病毒感染疾病的臨床實驗相關之基本資料和數據,為您彙整實驗數量及受驗者的募集情況,各階段趨勢,進行臨床實驗的主要製藥企業及研究機關簡介等資料。

簡介

  • 正黏液病毒感染疾病
  • 本報告概要

各地區的臨床實驗情形

  • 各國臨床實驗數量和平均實驗人數
    • 亞太地區的主要5個國家的臨床實驗數量
    • 歐洲的主要5個國家的臨床實驗數量
    • 北美的主要國家的臨床實驗數量
    • 中東·非洲的主要5個國家臨床實驗數量
    • 中南美的主要5個國家臨床實驗數量

G7各國臨床實驗數量:感染疾病臨床實驗上正黏液病毒感染疾病所佔的比例

G7各國的各階段臨床實驗數量

G7各國臨床實驗數量:各進展狀況

E7各國臨床實驗數量:感染疾病臨床實驗上正黏液病毒感染疾病所佔的比例

E7各國的各階段臨床實驗數量

E7各國臨床實驗數量:各進展狀況

各階段臨床實驗數量

  • 進行中的臨床實驗:各階段

各進展狀況臨床實驗數量

臨床實驗的目標達成情形

未完成的臨床實驗數量

一定期間所採用的實驗對像

贊助商類別的臨床實驗數量

有潛力的贊助商

正黏液病毒感染疾病治療藥臨床實驗的主要參與企業

有潛力的藥劑

臨床實驗簡介

  • 主要企業臨床實驗概要
    • GlaxoSmithKline plc
    • Novartis AG
    • Sanofi
    • AstraZeneca PLC
    • F. Hoffmann-La Roche Ltd.
    • CSL Limited
    • Pfizer Inc.
    • Baxter International Inc.
    • Novavax, Inc.
    • Johnson & Johnson
  • 有代表性的研究機關·醫院臨床實驗概要
    • The National Institute of Allergy and Infectious Diseases
    • University of Oxford
    • The University of Hong Kong
    • Centers for Disease Control and Prevention
    • National Hospital Organization Mie National Hospital
    • PATH
    • University Hospitals of Leicester NHS Trust
    • University of British Columbia
    • University of the Witwatersrand
    • Institut National de la Sante et de la Recherche Medicale

5個有代表性的臨床實驗簡介

附錄

目錄
Product Code: GDHC2490CTIDB

GlobalData's clinical trial report, "Orthomyxoviridae Infections Global Clinical Trials Review, H2, 2014" provides data on the Orthomyxoviridae Infections clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Orthomyxoviridae Infections. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Orthomyxoviridae Infections. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each
  • Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
  • Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

  • Understand the dynamics of a particular indication in a condensed manner
  • Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
  • Obtain discontinued trial listing for trials across the globe
  • Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Introduction
    • Orthomyxoviridae Infections
    • Report Guidance
  • Clinical Trials by Region
    • Clinical Trials and Average Enrollment by Country
      • Top Five Countries Contributing to Clinical Trials in Asia-Pacific
      • Top Five Countries Contributing to Clinical Trials in Europe
      • Top Countries Contributing to Clinical Trials in North America
      • Top Five Countries Contributing to Clinical Trials in Middle East and Africa
      • Top Five Countries Contributing to Clinical Trials in Central and South America
  • Clinical Trials by G7 Countries: Proportion of Orthomyxoviridae Infections to Infectious Disease Clinical Trials
  • Clinical Trials by Phase in G7 Countries
  • Clinical Trials in G7 Countries by Trial Status
  • Clinical Trials by E7 Countries: Proportion of Orthomyxoviridae Infections to Infectious Disease Clinical Trials
  • Clinical Trials by Phase in E7 Countries
  • Clinical Trials in E7 Countries by Trial Status
  • Clinical Trials by Phase
    • In Progress Trials by Phase
  • Clinical Trials by Trial Status
  • Clinical Trials by End Point Status
  • Unaccomplished Trials of Orthomyxoviridae Infections
  • Subjects Recruited Over a Period of Time
  • Clinical Trials by Sponsor Type
  • Prominent Sponsors
    • Top Companies Participating in Orthomyxoviridae Infections Therapeutics Clinical Trials
  • Prominent Drugs
  • Clinical Trial Profiles
    • Clinical Trial Overview of Top Companies
      • GlaxoSmithKline plc
      • Clinical Trial Overview of GlaxoSmithKline plc
      • Novartis AG
      • Clinical Trial Overview of Novartis AG
      • Sanofi
      • Clinical Trial Overview of Sanofi
      • AstraZeneca PLC
      • Clinical Trial Overview of AstraZeneca PLC
      • F. Hoffmann-La Roche Ltd.
      • Clinical Trial Overview of F. Hoffmann-La Roche Ltd.
      • CSL Limited
      • Clinical Trial Overview of CSL Limited
      • Pfizer Inc.
      • Clinical Trial Overview of Pfizer Inc.
      • Baxter International Inc.
      • Clinical Trial Overview of Baxter International Inc.
      • Novavax, Inc.
      • Clinical Trial Overview of Novavax, Inc.
      • Johnson & Johnson
      • Clinical Trial Overview of Johnson & Johnson
    • Clinical Trial Overview of Top Institutes / Government
      • The National Institute of Allergy and Infectious Diseases
      • Clinical Trial Overview of The National Institute of Allergy and Infectious Diseases
      • University of Oxford
      • Clinical Trial Overview of University of Oxford
      • The University of Hong Kong
      • Clinical Trial Overview of The University of Hong Kong
      • Centers for Disease Control and Prevention
      • Clinical Trial Overview of Centers for Disease Control and Prevention
      • National Hospital Organization Mie National Hospital
      • Clinical Trial Overview of National Hospital Organization Mie National Hospital
      • PATH
      • Clinical Trial Overview of PATH
      • University Hospitals of Leicester NHS Trust
      • Clinical Trial Overview of University Hospitals of Leicester NHS Trust
      • University of British Columbia
      • Clinical Trial Overview of University of British Columbia
      • University of the Witwatersrand
      • Clinical Trial Overview of University of the Witwatersrand
      • Institut National de la Sante et de la Recherche Medicale
      • Clinical Trial Overview of Institut National de la Sante et de la Recherche Medicale
  • Five Key Clinical Profiles
  • Appendix
    • Abbreviations
    • Definitions
    • Research Methodology
    • Secondary Research
    • About GlobalData
    • Contact Us
    • Disclaimer
    • Source

List of Tables

  • Orthomyxoviridae Infections Therapeutics, Global, Clinical Trials by Region, 2014*
  • Orthomyxoviridae Infections Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014*
  • Orthomyxoviridae Infections Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014*
  • Orthomyxoviridae Infections Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2014*
  • Orthomyxoviridae Infections Therapeutics Clinical Trials, Europe, Top Five Countries, 2014*
  • Orthomyxoviridae Infections Therapeutics Clinical Trials, North America, Top Countries, 2014*
  • Orthomyxoviridae Infections Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2014*
  • Orthomyxoviridae Infections Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2014*
  • Proportion of Orthomyxoviridae Infections to Infectious Disease Clinical Trials, G7 Countries (%), 2014*
  • Orthomyxoviridae Infections Therapeutics, G7 Countries, Clinical Trials by Phase, 2014*
  • Orthomyxoviridae Infections Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014*
  • Proportion of Orthomyxoviridae Infections to Infectious Disease Clinical Trials, E7 Countries (%), 2014*
  • Orthomyxoviridae Infections Therapeutics, E7 Countries, Clinical Trials by Phase, 2014*
  • Orthomyxoviridae Infections Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014*
  • Orthomyxoviridae Infections Therapeutics, Global, Clinical Trials by Phase, 2014*
  • Orthomyxoviridae Infections Therapeutics, Global, Clinical Trials In Progress by Phase 2014*
  • Orthomyxoviridae Infections Therapeutics, Global, Clinical Trials by Trial Status, 2014*
  • Orthomyxoviridae Infections Therapeutics Clinical Trials, Global, by End Point Status, 2014*
  • Orthomyxoviridae Infections Therapeutics, Global, Suspended Clinical Trials, 2014*
  • Orthomyxoviridae Infections Therapeutics, Global, Withdrawn Clinical Trials, 2014*
  • Orthomyxoviridae Infections Therapeutics, Global, Terminated Clinical Trials, 2014*
  • Orthomyxoviridae Infections Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
  • Orthomyxoviridae Infections Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014*
  • Orthomyxoviridae Infections Therapeutics Clinical Trials, Global, Key Sponsors, 2014*
  • Orthomyxoviridae Infections Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014*
  • Orthomyxoviridae Infections Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014*
  • Orthomyxoviridae Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline plc, 2014*
  • Orthomyxoviridae Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2014*
  • Orthomyxoviridae Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Sanofi, 2014*
  • Orthomyxoviridae Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by AstraZeneca PLC, 2014*
  • Orthomyxoviridae Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by F. Hoffmann-La Roche Ltd., 2014*
  • Orthomyxoviridae Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by CSL Limited, 2014*
  • Orthomyxoviridae Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2014*
  • Orthomyxoviridae Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Baxter International Inc., 2014*
  • Orthomyxoviridae Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Novavax, Inc., 2014*
  • Orthomyxoviridae Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Johnson & Johnson, 2014*
  • Orthomyxoviridae Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by The National Institute of Allergy and Infectious Diseases, 2014*
  • Orthomyxoviridae Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Oxford, 2014*
  • Orthomyxoviridae Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Hong Kong, 2014*
  • Orthomyxoviridae Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Centers for Disease Control and Prevention, 2014*
  • Orthomyxoviridae Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by National Hospital Organization Mie National Hospital, 2014*
  • Orthomyxoviridae Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by PATH, 2014*
  • Orthomyxoviridae Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by University Hospitals of Leicester NHS Trust, 2014*
  • Orthomyxoviridae Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by University of British Columbia, 2014*
  • Orthomyxoviridae Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by University of the Witwatersrand, 2014*
  • Orthomyxoviridae Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Institut National de la Sante et de la Recherche Medicale, 2014*

List of Figures

  • Orthomyxoviridae Infections Therapeutics, Global, Clinical Trials by Region (%), 2014*
  • Orthomyxoviridae Infections Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014*
  • Orthomyxoviridae Infections Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014*
  • Orthomyxoviridae Infections Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2014*
  • Orthomyxoviridae Infections Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014*
  • Orthomyxoviridae Infections Therapeutics Clinical Trials, North America, Top Countries (%), 2014*
  • Orthomyxoviridae Infections Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2014*
  • Orthomyxoviridae Infections Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2014*
  • Proportion of Orthomyxoviridae Infections to Infectious Disease Clinical Trials, G7 Countries (%), 2014*
  • Orthomyxoviridae Infections Therapeutics, G7 Countries, Clinical Trials by Phase, 2014*
  • Orthomyxoviridae Infections Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014*
  • Proportion of Orthomyxoviridae Infections to Infectious Disease Clinical Trials, E7 Countries (%), 2014*
  • Orthomyxoviridae Infections Therapeutics, E7 Countries, Clinical Trials by Phase, 2014*
  • Orthomyxoviridae Infections Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014*
  • Orthomyxoviridae Infections Therapeutics, Global, Clinical Trials by Phase (%), 2014*
  • Orthomyxoviridae Infections Therapeutics, Global, Clinical Trials In Progress by Phase, 2014*
  • Orthomyxoviridae Infections Therapeutics, Global, Clinical Trials by Trial Status, 2014*
  • Orthomyxoviridae Infections Therapeutics Clinical Trials, Global, by End Point Status, 2014*
  • Orthomyxoviridae Infections Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
  • Orthomyxoviridae Infections Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014*
  • Orthomyxoviridae Infections Therapeutics Clinical Trials, Global, Key Sponsors, 2014*
  • Orthomyxoviridae Infections Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014*
  • Orthomyxoviridae Infections Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014*
  • GlobalData Methodology
Back to Top